Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis: the TOLERANT Trial

NCT05251870 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT05251870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05251870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis: the TOLERANT Trial
Lead sponsor
UMC Utrecht
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 17, 2021
Completion date
August 31, 2025
Enrollment
18 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis